Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 42NETWORK 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 3Tumor-Agnostic 2Other hematologic neoplasm 2Lymphoid 2Gastrointestinal 2Breast 2

Conditions

Colorectal Neoplasms 2Rectal Neoplasms 1Pain 1Fatigue 1Colonic Neoplasms 1

Interventions

Fluorouracil 74Leucovorin 48Oxaliplatin 44Cisplatin 40Capecitabine 39Gemcitabine 37Radiotherapy 30Irinotecan 28Cetuximab 21Paclitaxel 15Bevacizumab 12Docetaxel 10Taxes 9durvalumab 8dehydroftorafur 8Surgical Procedures, Operative 8Mitomycin 8Specimen Handling 7Platinum 7Folfox protocol 7Carboplatin 7Albumin-Bound Paclitaxel 7130-nm albumin-bound paclitaxel 7S 1 (combination) 6Panitumumab 6Watchful Waiting 5Imatinib Mesylate 5Gene Expression Profiling 5Epirubicin 5tremelimumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Interviews as Topic × Gastrointestinal × Clear all
NCT07018869 2026-03-31

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

SWOG Cancer Research Network

Phase 3 Recruiting
1,057 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00410579 2010-12-17

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

NSABP Foundation Inc

Completed
744 enrolled
Gastrointestinal

Colonic Neoplasms, Fatigue, Pain, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡